Acrivon Therapeutics (ACRV) Shares Outstanding (Diluted) (2021 - 2026)
Acrivon Therapeutics (ACRV) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 64.41 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 115.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 138.28 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 556.90 Mn |
| 10 | Acrivon Therapeutics | 92.89 Mn | 92.89 Mn | - | 41.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.72 Mn |
| Mar 31, 2026 | 38.72 Mn |
| Dec 31, 2025 | 38.51 Mn |
| Sep 30, 2025 | 38.56 Mn |
| Jun 30, 2025 | 38.46 Mn |
| Mar 31, 2025 | 38.35 Mn |
| Dec 31, 2024 | 33.79 Mn |
| Sep 30, 2024 | 38.11 Mn |
| Jun 30, 2024 | 36.13 Mn |
| Mar 31, 2024 | 22.59 Mn |
| Dec 31, 2023 | 22.08 Mn |
| Sep 30, 2023 | 22.08 Mn |
| Jun 30, 2023 | 21.97 Mn |
| Mar 31, 2023 | 21.92 Mn |
| Dec 31, 2022 | 4.12 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 1.74 Mn |
| Sep 30, 2021 | 1.77 Mn |